PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+29.47%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.12B
AUM Growth
+$1.12B
(+22%)
Cap. Flow
+$76.8M
Cap. Flow
% of AUM
6.87%
Top 10 Holdings %
Top 10 Hldgs %
44.03%
Holding
175
New
50
Increased
49
Reduced
22
Closed
29
Top Buys
| 1 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$24.1M |
| 2 |
BLUE
bluebird bio
BLUE
|
$20.6M |
| 3 |
ANI Pharmaceuticals
ANIP
|
$17.6M |
| 4 |
Amicus Therapeutics
FOLD
|
$17.5M |
| 5 |
RLYP
RELYPSA INC COM
RLYP
|
$14.7M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$25.8M |
| 2 |
Neurocrine Biosciences
NBIX
|
$22.3M |
| 3 |
Arrowhead Research
ARWR
|
$18.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$15.5M |
| 5 |
DYAX
DYAX CORPORATION
DYAX
|
$13.8M |
Sector Composition
| 1 | Healthcare | 84.54% |
| 2 | Financials | 0.1% |
| 3 | Energy | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amicus Therapeutics
FOLD
$2.34B
| $120M | 10.07% | 14,439,444 +2,100,000 | +17% | +$17.5M |
|
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $79.6M | 6.68% | 3,565,267 -1,000,000 | -22% | -$22.3M |
|
3
Talphera
TLPH
$11.1M
| $44.2M | 3.71% | 6,574,060 | – | – |
|
4
Sarepta Therapeutics
SRPT
$1.78B
| $40.7M | 3.41% | 2,812,352 +215,661 | +8% | +$3.12M |
|
|
RLYP
5
DELISTED
RELYPSA INC COM
RLYP
| $38.2M | 3.2% | 1,239,142 +476,437 | +62% | +$14.7M |
|
|
RCPT
6
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $35.7M | 2.99% | 291,394 -22,200 | -7% | -$2.72M |
|
7
PTC Therapeutics
PTCT
$3.92B
| $34.8M | 2.92% | 671,736 | – | – |
|
8
Acadia Pharmaceuticals
ACAD
$4.38B
| $34.7M | 2.91% | 1,093,281 -4,633 | -0.4% | -$147K |
|
|
TSRO
9
DELISTED
TESARO, Inc.
TSRO
| $32.9M | 2.76% | 883,359 +175,075 | +25% | +$6.51M |
|
10
Xencor
XNCR
$580M
| $30.9M | 2.59% | 1,927,171 +4,464 | +0.2% | +$71.6K |
|
|
DYAX
11
DELISTED
DYAX CORPORATION
DYAX
| $26M | 2.18% | 1,852,000 -983,498 | -35% | -$13.8M |
|
12
Iovance Biotherapeutics
IOVA
$807M
| $25.3M | 2.12% | 3,214,549 +300,000 | +10% | +$2.36M |
|
|
BLCM
13
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $24.1M | 2.02% | +1,046,402 | New | +$24.1M |
|
14
Travere Therapeutics
TVTX
$1.56B
| $23.8M | 1.99% | 1,940,725 +561,588 | +41% | +$6.87M |
|
|
TARO
15
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $22.8M | 1.91% | 154,028 +13,093 | +9% | +$1.94M |
|
|
BLUE
16
DELISTED
bluebird bio
BLUE
| $20.6M | 1.73% | +225,000 | New | +$20.6M |
|
|
ARAV
17
DELISTED
Aravive, Inc. Common Stock
ARAV
| $19.7M | 1.66% | 931,171 +443,909 | +91% | +$9.41M |
|
|
ISEE
18
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $19.3M | 1.62% | 429,386 -90,779 | -17% | -$4.07M |
|
|
19
ANI Pharmaceuticals
ANIP
$2.03B
| $17.6M | 1.48% | +312,500 | New | +$17.6M |
|
|
AGN
20
DELISTED
ALLERGAN INC
AGN
| $17.6M | 1.47% | 82,583 +32,583 | +65% | +$6.93M |
|
21
Zimmer Biomet
ZBH
$21B
| $17.5M | 1.47% | 154,093 -98,407 | -39% | -$11.2M |
|
|
CELG
22
DELISTED
Celgene Corp
CELG
| $16.4M | 1.37% | 146,567 -230,881 | -61% | -$25.8M |
|
|
OTIC
23
DELISTED
Otonomy, Inc.
OTIC
| $15.1M | 1.27% | 454,306 -383,094 | -46% | -$12.8M |
|
|
24
Vertex Pharmaceuticals
VRTX
$100B
| $13.1M | 1.1% | 110,000 -130,142 | -54% | -$15.5M |
|
|
NEPT
25
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $12.8M | 1.08% | 6,750,444 +50,000 | +0.7% | +$95K |
|